<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 31 May 2021 19:59:58 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>重磅！FDA加速批准AMG510上市，KRAS-“不可成药”靶点的逆袭之路</title><link>https://mp.weixin.qq.com/s/p_t2-GCYYOrIp6phFEn6ug</link><description></description><content:encoded><![CDATA[重磅！FDA加速批准AMG510上市，KRAS-“不可成药”靶点的逆袭之路]]></content:encoded><pubDate>Mon, 31 May 2021 19:02:11 +0800</pubDate></item><item><title>抗体药物动态-20210531</title><link>https://mp.weixin.qq.com/s/Fg-XyZ1Tmfa-irjQxEQ06w</link><description></description><content:encoded><![CDATA[抗体药物动态-20210531]]></content:encoded><pubDate>Mon, 31 May 2021 19:02:11 +0800</pubDate></item><item><title>FDA发布双特异性抗体研发指南</title><link>https://mp.weixin.qq.com/s/UVmaa51E7YGs-h7MdqiXHA</link><description></description><content:encoded><![CDATA[FDA发布双特异性抗体研发指南]]></content:encoded><pubDate>Thu, 27 May 2021 19:03:44 +0800</pubDate></item><item><title>抗体药物动态-20210527</title><link>https://mp.weixin.qq.com/s/hD3uWVamP6RZ2V3SM_uo8g</link><description></description><content:encoded><![CDATA[抗体药物动态-20210527]]></content:encoded><pubDate>Thu, 27 May 2021 19:03:44 +0800</pubDate></item><item><title>记忆CD8+T细胞分类：表型与功能</title><link>https://mp.weixin.qq.com/s/hNpuQDZ6O0rOgfQc12TnIg</link><description></description><content:encoded><![CDATA[记忆CD8+T细胞分类：表型与功能]]></content:encoded><pubDate>Wed, 26 May 2021 19:08:25 +0800</pubDate></item><item><title>TACA靶向治疗进展：CAR-T和双抗</title><link>https://mp.weixin.qq.com/s/Pzet9gHqZ32mx7Qki2-XPw</link><description></description><content:encoded><![CDATA[TACA靶向治疗进展：CAR-T和双抗]]></content:encoded><pubDate>Tue, 25 May 2021 18:47:00 +0800</pubDate></item><item><title>抗体药物动态-20210525</title><link>https://mp.weixin.qq.com/s/OU4rFNYmz84COrh0EYwarQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210525]]></content:encoded><pubDate>Tue, 25 May 2021 18:47:00 +0800</pubDate></item><item><title>TROP-2 ADC药物临床实验总览</title><link>https://mp.weixin.qq.com/s/HXI_LF-dwQz3T3coWY90yg</link><description></description><content:encoded><![CDATA[TROP-2 ADC药物临床实验总览]]></content:encoded><pubDate>Thu, 20 May 2021 19:01:11 +0800</pubDate></item><item><title>“魔法子弹”ADC药物100亿黄金赛道竞争加剧！国产追赶加速，2款已申报上市，云顶新耀、荣昌生物....</title><link>https://mp.weixin.qq.com/s/7Lb20vz57yR7bVqg4W0h6Q</link><description></description><content:encoded><![CDATA[“魔法子弹”ADC药物100亿黄金赛道竞争加剧！国产追赶加速，2款已申报上市，云顶新耀、荣昌生物....]]></content:encoded><pubDate>Wed, 19 May 2021 17:48:06 +0800</pubDate></item><item><title>与HER2的天壤之别？HER3究竟能否成药！</title><link>https://mp.weixin.qq.com/s/b80wA_yVOo7G_jwuPXvcHw</link><description></description><content:encoded><![CDATA[与HER2的天壤之别？HER3究竟能否成药！]]></content:encoded><pubDate>Tue, 18 May 2021 19:14:16 +0800</pubDate></item><item><title>抗体药物动态-20210518</title><link>https://mp.weixin.qq.com/s/7ZlMSR1-iN_C80UgcloBoQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210518]]></content:encoded><pubDate>Tue, 18 May 2021 19:14:16 +0800</pubDate></item><item><title>SARS-CoV-2：6个你需要知道的变种病毒（印度+南非+巴西+英国+美国2）</title><link>https://mp.weixin.qq.com/s/L-xmvRwq7gG5IgBvZM4q7g</link><description></description><content:encoded><![CDATA[SARS-CoV-2：6个你需要知道的变种病毒（印度+南非+巴西+英国+美国2）]]></content:encoded><pubDate>Mon, 17 May 2021 18:49:27 +0800</pubDate></item><item><title>实体瘤中的CAR T细胞：挑战和机遇</title><link>https://mp.weixin.qq.com/s/k9j6jk0K8zsKh4x40sxclg</link><description></description><content:encoded><![CDATA[实体瘤中的CAR T细胞：挑战和机遇]]></content:encoded><pubDate>Fri, 14 May 2021 19:00:55 +0800</pubDate></item><item><title>抗体药物动态-20210514</title><link>https://mp.weixin.qq.com/s/8DZDyjOeEb2S8ym291n27A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210514]]></content:encoded><pubDate>Fri, 14 May 2021 19:00:55 +0800</pubDate></item><item><title>免疫检查点与自身免疫性疾病</title><link>https://mp.weixin.qq.com/s/Q6kpYUBSrSuDQkCnUSGrSw</link><description></description><content:encoded><![CDATA[免疫检查点与自身免疫性疾病]]></content:encoded><pubDate>Thu, 13 May 2021 18:50:20 +0800</pubDate></item></channel></rss>